Literature DB >> 8496317

Report of a kindred with X-linked (or autosomal dominant sex-limited) 46,XY partial gonadal dysgenesis.

P Y Fechner1, S M Marcantonio, T Ogata, T O Rosales, K D Smith, P N Goodfellow, C J Migeon, G D Berkovitz.   

Abstract

The condition termed 46,XY complete gonadal dysgenesis is characterized by the lack of testicular determination with resulting streak gonads, normal Mullerian structures, and female external genitalia. In the partial form, there is incomplete testicular determination with a wide range in the degree of ambiguous genitalia and sexual duct development. We evaluated a kindred in which a partial form of 46,XY gonadal dysgenesis occurred in four subjects from two generations. Pedigree analysis indicated an X-linked or possibly an autosomal sex-limited mode of inheritance. All affected subjects were ascertained because of ambiguous genitalia with minimal virilization. At 10 days of age, the proband had a subnormal plasma level of testosterone, and at 4 months, there was no rise in plasma T after stimulation with hCG. At laparotomy, a dysgenetic gonad was found on the right side, but no gonad was found on the left side. A vas deferens was present on the right, indicating the presence of functional Leydig cells early in fetal life. In the other affected subjects, gonadal tissue was also limited to one side of the abdomen and showed poorly developed seminiferous tubules. The sex-determining region Y gene, which encodes the testis-determining factor, was present and unaltered in the genomic DNA of all affected subjects. Duplication of the distal short arm of the X-chromosome has been associated with 46,XY complete gonadal dysgenesis in some patients. In our studies, Southern blot analysis revealed that sequences of the distal short arm of the X-chromosome (DXS9 to DXS84) were present in single copy, excluding a large duplication in this area of the X. Several kindreds with familial 46,XY complete gonadal dysgenesis have been reported; five of them had evidence of an X-linked mode of inheritance. Our study of a kindred with 46,XY partial gonadal dysgenesis further supports the role of an X chromosome gene in testicular determination. Evidence of some fetal Leydig cell function in the affected subjects of our report suggests that mutations of the putative X-chromosome gene can result in a partial as well as complete defect in testicular determination.

Entities:  

Mesh:

Year:  1993        PMID: 8496317     DOI: 10.1210/jcem.76.5.8496317

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  4 in total

1.  A novel postzygotic nonsense mutation in SRY in familial XY gonadal dysgenesis.

Authors:  J R Bilbao; L Loridan; L Castaño
Journal:  Hum Genet       Date:  1996-04       Impact factor: 4.132

2.  Gene dosage of DAX-1, determining in sexual differentiation: duplication of DAX-1 in two sisters with gonadal dysgenesis.

Authors:  Mary García-Acero; Mónica Molina; Olga Moreno; Andrea Ramirez; Catalina Forero; Camila Céspedes; Juan Carlos Prieto; Jaime Pérez; Fernando Suárez-Obando; Adriana Rojas
Journal:  Mol Biol Rep       Date:  2019-03-16       Impact factor: 2.316

Review 3.  Hypogonadism and Cryptorchidism.

Authors:  Wiwat Rodprasert; Helena E Virtanen; Juho-Antti Mäkelä; Jorma Toppari
Journal:  Front Endocrinol (Lausanne)       Date:  2020-01-15       Impact factor: 5.555

4.  Pathogenic variants in the DEAH-box RNA helicase DHX37 are a frequent cause of 46,XY gonadal dysgenesis and 46,XY testicular regression syndrome.

Authors:  Ken McElreavey; Anne Jorgensen; Caroline Eozenou; Tiphanie Merel; Joelle Bignon-Topalovic; Daisylyn Senna Tan; Denis Houzelstein; Federica Buonocore; Nick Warr; Raissa G G Kay; Matthieu Peycelon; Jean-Pierre Siffroi; Inas Mazen; John C Achermann; Yuliya Shcherbak; Juliane Leger; Agnes Sallai; Jean-Claude Carel; Laetitia Martinerie; Romain Le Ru; Gerard S Conway; Brigitte Mignot; Lionel Van Maldergem; Rita Bertalan; Evgenia Globa; Raja Brauner; Ralf Jauch; Serge Nef; Andy Greenfield; Anu Bashamboo
Journal:  Genet Med       Date:  2019-07-24       Impact factor: 8.822

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.